Med BioGene Update to Ongoing Signal Genetics LLC and Respira Lawsuit
2/25/2013 8:04:39 AM
More...
|
Signal Genetics LLC to Buy ChipDX LLC to Gain Cancer Diagnostics
2/2/2012 10:35:19 AM
More...
|
Signal Genetics LLC Announces Publication of Meta-Analysis of its Colon Cancer Test-Previstage(TM) GCC Confirming Prognostic Capabilities in Patients with Colon Cancer
1/24/2012 9:20:59 AM
More...
|
Signal Genetics LLC Announces Launch of Next Generation Genetic Multiple Myeloma Predictive Testing Product-MyPRS Plus(TM)
12/9/2011 10:45:21 AM
More...
|
Signal Genetics LLC and DiagnoCure (CUR) Announce a US $13.3 Million Collaboration for the Commercialization of Previstage(TM) GCC Colorectal Cancer Staging Test
6/29/2011 7:01:02 AM
More...
|
Signal Genetics LLC Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
5/26/2011 4:54:49 PM
More...
|
Signal Genetics LLC and Pronto Diagnostics Announce Distribution Agreement
4/4/2011 8:12:46 AM
More...
|
Med BioGene Charged with Fraud, and Precision Therapeutics, Inc. Charged with Tortious Interference in Amended Complaint by Signal Genetics LLC
2/25/2011 7:33:47 AM
More...
|
Signal Genetics LLC Announces Med BioGene Charged with Breach of Business Agreement, Bad Faith and Violation of Confidentiality Agreements
2/14/2011 10:39:06 AM
More...
|
Signal Genetics LLC and Caris Life Sciences Announce Commercialization Partnership for New Myeloma Gene Expression Test
1/5/2011 8:55:21 AM
More...
|
|